Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts

Documenti analoghi

• Risk factors for suicide in patients with pancreatic ductal adenocarcinoma: A population‐based study
  di: Chao Wang, et al.
  Pubblicazione: (2024)
• ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma
  di: Yifeng Sun, et al.
  Pubblicazione: (2024)
• Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma
  di: Junki Fukuda, et al.
  Pubblicazione: (2024)
• Real‐world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications
  di: Toshifumi Doi, et al.
  Pubblicazione: (2024)
• Hexokinase 2 nonmetabolic function‐mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression
  di: Yingying Tong, et al.
  Pubblicazione: (2024)